Bringing the fundamentals into focus…
Bringing the fundamentals into focus…
FRNM · against 451 other Healthcare companies of similar size
Ranked #416 of 452 · scores higher than 0% of peers
Bars: peers in each 10-point band of the valuation score139 peers with a valuation score of 0–9, including FRNM · Click a bar to see the companies
Mainly because of its earnings yield and EBITDA yield, which are weaker than most Healthcare peers.
| Metric | FRNM | Peer median | Better than | Position among peers | Weight |
|---|---|---|---|---|---|
| Earnings yieldHigher is better · 442 reported | -17.8% | 1.4% | 10% | 30% | |
| EBITDA yieldHigher is better · 455 reported | -7.3% | 4.3% | 19% | 50% | |
| Free cash flow yieldHigher is better · 205 reported | Not reported | -1.6% | — | — | 20% |
| Book yieldHigher is better · 447 reported | -461.4% | 40.8% | 0% | Context only |
A metric that is not reported is left out of the score; the other weights are rescaled.
| Rank | Company | Market cap | Valuation | Overall |
|---|---|---|---|---|
| 1 | 14.2B HKD (≈$1.8B) | 99 | 64 | |
| 1 | 12.9B HKD (≈$1.7B) | 99 | 83 | |
| 1 | 226.3B JPY (≈$1.5B) | 99 | 77 | |
| 1 | 40.2B MXN (≈$2.2B) | 99 | 71 | |
| 1 | 14.8B MXN (≈$800M) | 99 | 61 | |
| 416 | 14.2B CNY (≈$2.0B) | 0 | 10 | |
| 416 | 1.0B USD | 0 | 35 | |
| 416 | 617M USD | 0 | 28 | |
| 416 | 1.2B USD | 0 | ||
| 416 | 1.2B USD | 0 | 3 | |
| 416 | 1.8B USD | 0 | 30 | |
| 416 | 1.2B CHF (≈$1.3B) | 0 | 28 | |
| 416 | 952M USD | 0 | 3 | |
| 416 | 1.4B USD | 0 |
Scores are sector-relative percentiles from the latest snapshot, always calculated against the whole sector: narrowing the comparison group changes who you compare with, not the scores. Missing metrics are left out and the remaining weights rescaled. How we score